Literature DB >> 15297541

In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Laurent Poirel1, Claire Héritier, Colette Spicq, Patrice Nordmann.   

Abstract

Four clonally related Escherichia coli strains were isolated successively from bile duct of a girl suffering from sclerosing cholangitis. One of them, selected after an imipenem-containing regimen, was resistant to carbapenems and to broad-spectrum cephalosporins due to a plasmid-mediated cephalosporinase, CMY-2, and the lack of outer membrane proteins OmpF and OmpC.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15297541      PMCID： PMC497580          DOI： 10.1128/JCM.42.8.3831-3833.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

Review 1.  New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

2.  Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.

Authors:  A Carattoli; F Tosini; W P Giles; M E Rupp; S H Hinrichs; F J Angulo; T J Barrett; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 4.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

5.  Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem.

Authors:  Laurent Poirel; Claire Héritier; Isabelle Podglajen; Wladimir Sougakoff; Laurent Gutmann; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long-term antibiotic therapy.

Authors:  A S Low; F M MacKenzie; I M Gould; I R Booth
Journal:  Mol Microbiol       Date:  2001-11       Impact factor: 3.501

7.  Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.

Authors:  James A Karlowsky; Mark E Jones; Clyde Thornsberry; Ian R Friedland; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

8.  Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production.

Authors:  L Armand-Lefèvre; V Leflon-Guibout; J Bredin; F Barguellil; A Amor; J M Pagès; M-H Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

9.  Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.

Authors:  R Odeh; S Kelkar; A M Hujer; R A Bonomo; P C Schreckenberger; J P Quinn
Journal:  Clin Infect Dis       Date:  2002-06-24       Impact factor: 9.079

10.  A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated amp C beta-lactamase: an emerging concern in pediatrics?

Authors:  Claudia M Hoyen; Andrea M Hujer; Kristine M Hujer; Steven H Marshall; Lenore Carias; Philip Toltzis; Louis B Rice; Robert A Bonomo
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431
View more
  33 in total

1.  Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.

Authors:  Hedi Mammeri; Marc Van De Loo; Laurent Poirel; Luis Martinez-Martinez; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.

Authors:  Hervé Dupont; Pascaline Choinier; David Roche; Sandine Adiba; Megan Sookdeb; Catherine Branger; Erick Denamur; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

4.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

5.  Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.

Authors:  Hervé Dupont; Olivier Gaillot; Anne-Sophie Goetgheluck; Claire Plassart; Jean-Philippe Emond; Marion Lecuru; Nicolas Gaillard; Sarah Derdouri; Baptiste Lemaire; Marion Girard de Courtilles; Vincent Cattoir; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

6.  IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.

Authors:  William C Shropshire; Samuel L Aitken; Reed Pifer; Jiwoong Kim; Micah M Bhatti; Xiqi Li; Awdhesh Kalia; Jessica Galloway-Peña; Pranoti Sahasrabhojane; Cesar A Arias; David E Greenberg; Blake M Hanson; Samuel A Shelburne
Journal:  J Antimicrob Chemother       Date:  2021-01-19       Impact factor: 5.790

7.  Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China.

Authors:  Jia Chang Cai; Rong Zhang; Yan Yan Hu; Hong Wei Zhou; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

8.  Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC beta-lactamases in Korean respiratory isolates of Klebsiella pneumoniae.

Authors:  Jong Hwa Yum; Shinyoung Kim; Hyukmin Lee; Dongeun Yong; Kyungwon Lee; Sang-Nae Cho; Yunsop Chong
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

9.  Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China.

Authors:  Douglas M Warner; Qiwen Yang; Valérie Duval; Minjun Chen; Yingchun Xu; Stuart B Levy
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

10.  Ertapenem resistance of Escherichia coli.

Authors:  Marie-Frédérique Lartigue; Laurent Poirel; Claire Poyart; Hélène Réglier-Poupet; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.